DUBAI, UAE: Today, uMore announced it has joined, TheVentureCity's Product-Led Growth Program, an international venture acceleration program that focuses on product, growth and access to capital.

uMore is a digital health screening and recommendation platform that uses machine learning and digital phenotyping to offer users accessible and personalised mental health care. The platform launched in Mid-December 2020, has over 3.000 users and is one of the UAE’s Top 50 apps under Health and Fitness. The platform is showing promising results, with early users show improvements with just two weeks of usage.

As a TheVentureCity start-up, uMore will join a portfolio of over 70 industry-leading start-ups, including renowned names such as Cabify, Optimus Ride, Spotahome, 4iQ and RecargaPay.

"We are very excited about the opportunity that TheVentureCity gives us, not only to validate our work but also to scale at super-sonic speed," said Maria de Freitas, CEO and CoFounder of uMore.

Upon being accepted into the program, uMore received an investment of 120.000 USD, representing the first international investment in the company.

Maria added: "What we're most looking forward to is that the program has a product-led growth approach, and that's strongly aligned with our values. At uMore, we learn by continuously iterating, which allows us to test our hypotheses in real-time. We invest in experiences to drive growth, and we prioritise impact over effort. We believe that together with TheVentureCity's global community of best-in-class, technology-focused mentors, the sky is the limit."

TheVentureCity is led by CEO Laura Gonzalez-Estefani, an early employee of Facebook. The strength of TheVentureCity comes from the team of hyper-growth company operators, investors and past entrepreneurs that work with a hands-on, tailored approach during the 5-month Product-Led Growth Program.  

”We are excited to partner with Maria and her team, investing their first ticket and getting to work with them closely on the first few months of their journey. In uMore, we’ve found a great executional team that has shown relevant early traction and is committed to a mission in a market, mental health care, we deeply care about. We can’t wait to see what’s next for uMore.” said Fernando Dal Re Olleros, VP Product-Led Growth Program EMEA at TheVentureCity.

About uMore 

uMore is setting a new standard in mental healthcare. By combining vital data and biomarkers, we help users screen, track and treat their mental wellbeing. uMore has won various awards, including first place at the TechStars Startup Weekend UK COVID 19 Edition, 2020 STEP Anywhere, TikToks' PitchUpInTheSky and the MIT Enterprise Forum Arab Startup 2021 Competition.

Learn more about uMore at www.umore.app  

About TheVentureCity 

TheVentureCity, an international, operator-led venture acceleration model designed to make the global entrepreneurial ecosystem more diverse, international, and accessible to fair capital.

Since its launch in 2017, the organisation has been built on the principle that success should not be dependent on proximity to Silicon Valley. Aside from being an active investor in high growth startups, TheVentureCity run an ongoing 5-month Product-Led Growth Program, which is open to startups in its core markets of EMEA, the USA and Latin America.

Learn more about TheVentureCity at www.theventure.city 

Send us your press releases to pressrelease.zawya@refinitiv.com

© Press Release 2021

Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.

The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.

To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.